Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danicamtiv in Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07210723Phase 3Recruiting
- Sponsor
- Kardigan
- Start
- Feb 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of danicamtiv in dilated cardiomyopathy (DCM), sponsored by Kardigan. Started Feb 2026; status: recruiting.
02
Drugs
danicamtiv
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT07210723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07210723.